We are de-risking biomedical innovation, turning biomedical knowledge into social and economic value.
More than three decades later, we remain committed in pursuit of pharmaceutical innovation, providing high quality products and striving to deliver superior business results.
The patient is at the heart of what we do, making decisions regarding biometric innovation is usually a complicated and chaotic procedure as it consists of various product options, various facets to ascertain these on, and multiple evaluations at all levels.
Discover our therapeutic areas, where we continuously invest to innovate and deliver therapeutic solutions for patient’s benefit.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
5
Aug 2026
Neandertals were generally more strongly built than most people living today. Their bones show signs of large muscles, and they had characteristic features such as prominent brow ridges and relatively short tooth roots.
5
Aug 2026
A new open resource of patient-derived cancer models has enabled researchers to create the first large-scale map of the genes that cancers rely on to survive, offering new routes for research into better and less toxic treatments for patients.
5
Aug 2026
Toddlers who ate iron- and zinc-biofortified pearl millet for nine months did not experience adverse effects typically associated with increased iron intake and developed gut microbiomes with distinct and potentially beneficial changes, according to a new study led by researchers at Cornell University's Joan Klein Jacobs Center for Precision Nutrition and Health.
5
Aug 2026
A new economic evaluation from the University of California San Diego School of Medicine has revealed that Mindfulness-Oriented Recovery Enhancement (MORE) - an innovative, evidence-based, neuroscience-informed therapy for opioid misuse and chronic pain - provides $12 in cost savings for every dollar spent, between two and six times more cost effective than other addiction treatments such as residential or intensive outpatient treatment.